PAK2 and familial pancreatic carcinoma: ROC analysis indicated good discriminative ability of PAK2 for pancreatic cancer liver metastasis in the GSE19279 cohort (AUC=0.73, Figure 4C) and GSE71729 cohort (AUC=0.7, Figure 4D).